glp-1 drugs semaglutide from the Gray Market Diabetes advocacy group discourages use

Sensitivity to insulin Medical science has shown that type 2 Diabetes mellitus which is insulin resistance results in skin damage because it makes the skin natural barrier weak and compromises immunity

Because tirzepatide is more potent, your provider will typically start you at an equivalent tier rather than your semaglutide dose

This means survodutide may provide additional benefits for fat loss specifically, particularly visceral and liver fat, beyond what GIP/GLP-1 dual agonism achieves

There are potential side effects, many gastrointestinal in nature, and your provider will be able to give you tips on how to reduce them.